5/2/2016. Dr Brooks has no relevant financial affiliations to disclose. (Update 04/15/16) Learning Objectives
|
|
- Brent Cook
- 6 years ago
- Views:
Transcription
1 Persistent Challenge of HIV Transmission Control in Injection Drug Use: The Indiana Outbreak John T. Brooks, MD Senior Medical Advisor, Division of HIV/AIDS Prevention National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Centers for Disease Control and Prevention Atlanta, Georgia FINAL: 04/11/2016 Washington DC: April 15, 2016 Financial Relationships With Commercial Entities Dr Brooks has no relevant financial affiliations to disclose. (Update 04/15/16) Slide 2 of 52 Learning Objectives After attending this presentation, participants will be able to: Characterize the challenges faced when responding to a rural outbreak of HIV infection among persons who inject drugs Describe how patterns of injection drug use are changing in the United States Slide 3 of 52 1
2 Diagnoses, n 5/2/2016 In 2014, what fraction of new HIV diagnoses were estimated as attributable to injection drug use: 25% % 36% 29% % % 11% % Slide 4 of 52 In the last 5 years, the number of new HIV diagnoses estimated as attributable to injection drug use has been: 21% 1. Stable 25% 2. Declining 43% 3. Rising 11% 4. All over the place Slide 5 of 52 Slide 6 of 52 Number of HIV Infections Diagnosed among Adults and Adolescents, by Transmission Category, United States and 6 Dependent Areas 30,000 Male-to-male sexual contact 25,000 20,000 15,000 Heterosexual contact 63% decline over 10 years 6% of all HIV infections in ,000 5,000 6,408 Injection drug use 2, Year 2
3 Slide 7 of 52 Indiana HIV Outbreak: Geography Scott County pop. 24,000; Austin city pop. 4,200 Slide 8 of 52 Rural southeastern region of state Scott County ranked 92 nd in many health and social indicators among Indiana s 92 counties Lowest life expectancy 9% unemployment 19% poverty 21% no high school Many uninsured Indiana HIV Outbreak Summary Slide 9 of 52 In early 2015, 11 new HIV infections diagnosed in Scott County, IN Over past decade, <1 HIV new infection in Scott County per year As of February 1, new HIV diagnosis >90% coinfected with hepatitis C virus Response required a large and intensive collaboration of local, state and federal public health resources in partnership with the community Establish extent of the HIV infections Institute prevention and control measures Transmissions occurred in a dense network of persons who inject drugs Opioid analgesic oxymorphone 3
4 Slide 10 of 52 Demographics of HIV-infected Cases (N=181) Median age 34 years, interquartile range % male 99% non-hispanic white 96% injected drugs in past 12 months Peters P et al., in press Slide 11 of 52 Diagnoses of HIV Infection Among Persons Who Inject Drugs by Sex and Race/Ethnicity, 2014 United States and 6 Dependent Areas 4% Males N = 1,672 Females N = 1,060 4% 27% 41% 34% 43% Historical demography Mostly urban Male > female Mostly non-white 28% 19% Black, African-American Hispanic/Latino a White Other Note. Data include persons with a diagnosis of HIV infection regardless of stage of disease at diagnosis. All displayed data have been statistically adjusted to account for reporting delays, but not for incomplete reporting. a Hispanics/Latinos can be of any race. Slide 12 of 52 Diagnoses of HIV Infection Among Persons Who Inject Drugs by Sex and Race/Ethnicity, 2014 United States and 6 Dependent Areas Males N = 1,672 Females N = 1,060 69% 62% Historical demography Mostly urban Male > female Mostly non-white Black, African-American Hispanic/Latino White Other Note. Data include persons with a diagnosis of HIV infection regardless of stage of disease at diagnosis. All displayed data have been statistically adjusted to account for reporting delays, but not for incomplete reporting. a Hispanics/Latinos can be of any race. 4
5 HIV Diagnoses per Week 16-Nov 23-Nov 30-Nov 7-Dec 14-Dec 21-Dec 28-Dec 4-Jan 11-Jan 18-Jan 25-Jan 1-Feb 8-Feb 15-Feb 22-Feb 1-Mar 8-Mar 15-Mar 22-Mar 29-Mar 5-Apr 12-Apr 19-Apr 26-Apr 3-May 10-May 17-May 24-May 31-May 7-Jun 14-Jun 21-Jun 28-Jun 5-Jul 12-Jul 19-Jul 26-Jul 2-Aug 9-Aug 16-Aug 23-Aug 30-Aug 6-Sep 13-Sep 20-Sep 27-Sep 4-Oct 11-Oct 18-Oct 25-Oct 1-Nov 8-Nov 15-Nov 22-Nov 29-Nov 6-Dec 13-Dec 20-Dec 27-Dec 3-Jan 10-Jan 17-Jan 24-Jan 31-Jan 5/2/2016 Slide 13 of 52 Demographics of HIV-infected Cases (N=181) Median age 34 years, interquartile range % male 99% non-hispanic white 96% injected drugs in past 12 months 92% oxymorphone 27% heroin, 23% methamphetamine, 9% cocaine Peters P et al., in press Slide 14 of 52 Drug Use among HIV-infected Cases (N=108) Multigenerational users Daily injections: 4-15 Number of needle-sharing partners per injection event: 1-6 Sharing of injection equipment common Oxymorphone ER with INTAC Tablet Images* GENERIC oxymorphone ER Tablet Images* Early Release, MMWR Morb Mortal Wkly Report 2015, April 24, 2015 HIV Diagnoses by Week, Indiana HIV Outbreak (N=188) Slide 15 of Detect and confirm Peters P et al., in press and Indiana State Department of Health Week Ending 5
6 HIV Diagnoses per Week HIV Diagnoses per Week HIV Diagnoses per Week 16-Nov 23-Nov 30-Nov 7-Dec 14-Dec 21-Dec 28-Dec 4-Jan 11-Jan 18-Jan 25-Jan 1-Feb 8-Feb 15-Feb 22-Feb 1-Mar 8-Mar 15-Mar 22-Mar 29-Mar 5-Apr 12-Apr 19-Apr 26-Apr 3-May 10-May 17-May 24-May 31-May 7-Jun 14-Jun 21-Jun 28-Jun 5-Jul 12-Jul 19-Jul 26-Jul 2-Aug 9-Aug 16-Aug 23-Aug 30-Aug 6-Sep 13-Sep 20-Sep 27-Sep 4-Oct 11-Oct 18-Oct 25-Oct 1-Nov 8-Nov 15-Nov 22-Nov 29-Nov 6-Dec 13-Dec 20-Dec 27-Dec 3-Jan 10-Jan 17-Jan 24-Jan 31-Jan 16-Nov 23-Nov 30-Nov 7-Dec 14-Dec 21-Dec 28-Dec 4-Jan 11-Jan 18-Jan 25-Jan 1-Feb 8-Feb 15-Feb 22-Feb 1-Mar 8-Mar 15-Mar 22-Mar 29-Mar 5-Apr 12-Apr 19-Apr 26-Apr 3-May 10-May 17-May 24-May 31-May 7-Jun 14-Jun 21-Jun 28-Jun 5-Jul 12-Jul 19-Jul 26-Jul 2-Aug 9-Aug 16-Aug 23-Aug 30-Aug 6-Sep 13-Sep 20-Sep 27-Sep 4-Oct 11-Oct 18-Oct 25-Oct 1-Nov 8-Nov 15-Nov 22-Nov 29-Nov 6-Dec 13-Dec 20-Dec 27-Dec 3-Jan 10-Jan 17-Jan 24-Jan 31-Jan 16-Nov 23-Nov 30-Nov 7-Dec 14-Dec 21-Dec 28-Dec 4-Jan 11-Jan 18-Jan 25-Jan 1-Feb 8-Feb 15-Feb 22-Feb 1-Mar 8-Mar 15-Mar 22-Mar 29-Mar 5-Apr 12-Apr 19-Apr 26-Apr 3-May 10-May 17-May 24-May 31-May 7-Jun 14-Jun 21-Jun 28-Jun 5-Jul 12-Jul 19-Jul 26-Jul 2-Aug 9-Aug 16-Aug 23-Aug 30-Aug 6-Sep 13-Sep 20-Sep 27-Sep 4-Oct 11-Oct 18-Oct 25-Oct 1-Nov 8-Nov 15-Nov 22-Nov 29-Nov 6-Dec 13-Dec 20-Dec 27-Dec 3-Jan 10-Jan 17-Jan 24-Jan 31-Jan 5/2/2016 HIV Diagnoses by Week, Indiana HIV Outbreak (N=188) Slide 16 of Detect and confirm Deploy emergency command, HIV testing, contact tracing, services Jail-based testing: local and sentinel Teams of disease intervention specialists Point-of-care rapid test Venous blood draw (e.g., confirmation, acute HIV, HCV) Provided prevention education Directed to services: Treatment antiretroviral therapy Prevention addiction and harm reduction, PrEP 0 Peters P et al., under review and Indiana State Department of Health Week Ending HIV Diagnoses by Week, Indiana HIV Outbreak (N=188) Slide 17 of Detect and confirm Deploy emergency command, HIV testing, contact tracing, services Consolidate case management, HIV treatment, prevention services Peters P et al., under review and Indiana State Department of Health Week Ending HIV Diagnoses by Week, Indiana HIV Outbreak (N=188) Slide 18 of Detect and confirm Deploy emergency command, HIV testing, contact tracing, services Consolidate case management, HIV treatment, prevention services Retesting blitz Peters P et al., under review and Indiana State Department of Health Week Ending 6
7 HIV Diagnoses per Week HIV Diagnoses per Week 16-Nov 23-Nov 30-Nov 7-Dec 14-Dec 21-Dec 28-Dec 4-Jan 11-Jan 18-Jan 25-Jan 1-Feb 8-Feb 15-Feb 22-Feb 1-Mar 8-Mar 15-Mar 22-Mar 29-Mar 5-Apr 12-Apr 19-Apr 26-Apr 3-May 10-May 17-May 24-May 31-May 7-Jun 14-Jun 21-Jun 28-Jun 5-Jul 12-Jul 19-Jul 26-Jul 2-Aug 9-Aug 16-Aug 23-Aug 30-Aug 6-Sep 13-Sep 20-Sep 27-Sep 4-Oct 11-Oct 18-Oct 25-Oct 1-Nov 8-Nov 15-Nov 22-Nov 29-Nov 6-Dec 13-Dec 20-Dec 27-Dec 3-Jan 10-Jan 17-Jan 24-Jan 31-Jan 16-Nov 23-Nov 30-Nov 7-Dec 14-Dec 21-Dec 28-Dec 4-Jan 11-Jan 18-Jan 25-Jan 1-Feb 8-Feb 15-Feb 22-Feb 1-Mar 8-Mar 15-Mar 22-Mar 29-Mar 5-Apr 12-Apr 19-Apr 26-Apr 3-May 10-May 17-May 24-May 31-May 7-Jun 14-Jun 21-Jun 28-Jun 5-Jul 12-Jul 19-Jul 26-Jul 2-Aug 9-Aug 16-Aug 23-Aug 30-Aug 6-Sep 13-Sep 20-Sep 27-Sep 4-Oct 11-Oct 18-Oct 25-Oct 1-Nov 8-Nov 15-Nov 22-Nov 29-Nov 6-Dec 13-Dec 20-Dec 27-Dec 3-Jan 10-Jan 17-Jan 24-Jan 31-Jan 5/2/2016 HIV Diagnoses by Week, Indiana HIV Outbreak (N=188) Slide 19 of Detect and confirm Deploy emergency command, HIV testing, contact tracing, services Consolidate case management, HIV treatment, prevention services Retesting blitz Adult prevalence as of February 1, 2016 Scott County (18,264*): 1.0 % Austin, if home for 80% of cases (3,143*): 4.6 % 5 0 Week Ending Peters P et al., under review and Indiana State Department of Health *estimated population age >18 years, U.S. Census HIV Diagnoses by Week, Indiana HIV Outbreak (N=188) Slide 20 of Detect and confirm Deploy emergency command, HIV testing, contact tracing, services Consolidate case management, HIV treatment, prevention services Retesting blitz Declined earlier testing Finally came in for testing or diagnosed at incarceration Peters P et al., under review and Indiana State Department of Health Week Ending Laboratory Investigation, 2015 Indiana HIV Outbreak Phylogenetic Analysis of pol Sequences and Recency Testing* Slide 21 of 52 SOURCE OF SAMPLE Indiana outbreak investigation Indiana reference sample (non-outbreak related) GenBank reference 157 isolates Single strain of HIV-1 Mean nucleotide identity 99.7% (1302 base pairs) No antiretroviral drug resistance detected All infections epidemiologically linked to Scott County Availability of near real-time pol sequencing confirmed limited geographic spread of outbreak* *Poster 215: Campbell et al., Infer and characterize a transmission network in an opioid-driven HIV-1 outbreak 7
8 Laboratory Investigation, 2015 Indiana HIV Outbreak Phylogenetic Analysis of pol Sequences and Recency Testing* Slide 22 of 52 SOURCE OF SAMPLE Indiana outbreak investigation Indiana reference sample (non-outbreak related) GenBank reference 157 isolates Single strain of HIV-1 Mean nucleotide identity 99.7% (1302 base pairs) No antiretroviral drug resistance detected All infections epidemiologically linked to Scott County Availability of near real-time pol sequencing confirmed limited geographic spread of outbreak 85% of infections recent* (limited in time) * Recency testing was performed using a Modified BioRad 1/2 Plus O Assay with avidity index cutoff set at 30%, corresponding to approximately 221 days Major Logistical Challenges Responding to Outbreak Slide 23 of 52 Very few affected persons were employed or insured Lacked documents* to enroll in state-supported program ( One-Stop Shop ) Limited HIV awareness, substantial misinformation Unaware of transmission risks and treatment benefits Distrust between PWID community and law enforcement No outpatient HIV/HCV care available in the community Insufficient addiction services, including medication-assisted therapy Syringe service program not permitted by state law * Birth certificate, driver s license, Social Security card Emergency Declaration and New Law Permitted Syringe Exchange in Response to Outbreak Slide 24 of
9 Slide 25 of 52 Slide 26 of 52 Federal funds can be used for syringe service programs (except purchase of needles and syringes) if in consultation with CDC a need is demonstrated (i.e., significant increase in hepatitis infections, HIV outbreak) Impact of Syringe Exchange in Scott County Reductions in sharing syringes and injection equipment (n=148) Slide 27 of 52 p <0.001 p <0.001 p < % 20% 18% 19% 24% 10% 0% 2% Sharing syringes to inject Sharing syringes to divide drugs 4% 5% Sharing other injection equipment First visit Most recent visit (median 10 weeks after first visit) Patel et al. IDWeek 2015, abstract: Open Forum Infect Dis (Fall 2015) 2 (supplement 1): S69-S70 9
10 Slide 28 of 52 Why Did this Event Happen? Slide 29 of 52 What Had Changed? Time Magazine, June 15, 2015 Slide 30 of 52 10
11 Slide 31 of 52 Rates of motor vehicle traffic and drug overdose deaths, United States Source: DHHS, Addressing Prescription Drug Abuse in the United States Current Activities and Future Opportunities, September 2013 * Slide 32 of 52 Rates of motor vehicle traffic and drug overdose deaths, United States ,055 * 32,675 ** Source: DHHS, Addressing Prescription Drug Abuse in the United States Current Activities and Future Opportunities, September 2013 * MMWR Wkly Rep 2016, 64(50): ** Slide 33 of 52 Rates of motor vehicle traffic and drug overdose deaths, United States : Opioids involved: 30% of drug overdoses Source: DHHS, Addressing Prescription Drug Abuse in the United States Current Activities and Future Opportunities, September 2013 * 11
12 Slide 34 of 52 Rates of motor vehicle traffic and drug overdose deaths, United States : Opioids involved: 60% of drug overdoses 1999: Opioids involved: 30% of drug overdoses Source: DHHS, Addressing Prescription Drug Abuse in the United States Current Activities and Future Opportunities, September 2013 * Slide 35 of 52 Rates of opioid overdose deaths, opioid sales, and opioid substance abuse treatment admissions, United States Source: DHHS, Addressing Prescription Drug Abuse in the United States Current Activities and Future Opportunities, September 2013 Slide 36 of 52 Rates of opioid overdose deaths, opioid sales, and opioid substance abuse treatment admissions, United States Increasing opioid use Increasing injection of drugs Source: DHHS, Addressing Prescription Drug Abuse in the United States Current Activities and Future Opportunities, September
13 Number of cases per 100,000 population 5/2/2016 Rapid expansion of injection drug use heralded by epidemic of new HCV infections in areas with historically low rates of HIV infection Slide 37 of Acute HCV infections incidence per 100,000 population 0-1 >1-10 >10-20 >20-40 >40 Acute HCV infections incidence per 100,000 population 0-1 >1-10 >10-20 >20-40 >40 Suryaprasad Clin Infect Dis; 2014, 59(10): Rapid expansion of injection drug use heralded by epidemic of new HCV infections in areas with historically low rates of HIV infection Slide 38 of Acute HCV infections incidence per 100,000 population 0-1 >1-10 >10-20 >20-40 >40 Acute HCV infections incidence per 100,000 population 0-1 >1-10 >10-20 >20-40 >40 Suryaprasad Clin Infect Dis; 2014, 59(10): Rapid expansion of injection drug use heralded by epidemic of new HCV infections in areas with historically low rates of HIV infection Kentucky, Tennessee, Virginia, West Virginia Slide 39 of Incidence nonurban more than twice urban, and increasing faster Nonurban areas Urban areas Zibbell J et al. MMWR Morb Mortal Wkly Rep 2015, 64(17): , 13
14 Needle and Syringe Programs Reduce HIV Incidence 56% reduction in risk of HIV infection Slide 40 of 52 Aspinall E J et al. Int J. Epidemiolog. 2014, Courtesy of Richard Needle Opioid Substitution Therapy Reduces HIV Transmission 64% reduction in risk of HIV infection Slide 41 of 52 MacArthur G J et al. BMJ 2012, Courtesy of Richard Needle Explosive Increases in HIV Prevalence among PWID, HIV prevalence (%) 40% and higher prevalence may be reached within 1-2 years 100 New York, USA 80 Edinburgh, Scotland Bangkok, Thailand 60 Chiang Rai, Thailand Ruili, China 40 Manipur, India Ho Chi Minh, Vietnam 20 Kathmandu, Nepal Nikolaev, Ukraine 0 Odessa, Ukraine Slide 42 of UN Reference Group on HIV/AIDS Prevention and Care among IDU in Developing and Transitional Countries, Courtesy of Richard Needle 14
15 What can we do? Assess and reduce vulnerability to an outbreak Determine if unsafe injection of drugs is occurring Employ syringe service programs Diagnose and treat substance use disorder Slide 43 of 52 Enhance capacity to detect a change in HIV and HCV infections Test at drug treatment service sites, jails/prisons, hospitals Prepare an action plan in the event of an outbreak Delineate landscape of HIV/HCV prevention and treatment Establish relationships with local law enforcement Lessons from Indiana Slide 44 of 52 The U.S. is experiencing an expanding prescription drug and heroin epidemic that is driving increases in injection drug use Lessons from Indiana Slide 45 of 52 The U.S. is experiencing an expanding prescription drug and heroin epidemic that is driving increases in injection drug use A new and growing group of U.S. residents has become vulnerable to potentially explosive spread of HIV and HCV infection 15
16 Lessons from Indiana Slide 46 of 52 The U.S. is experiencing an expanding prescription drug and heroin epidemic that is driving increases in injection drug use A new and growing group of U.S. residents has become vulnerable to potentially explosive spread of HIV and HCV infection The events in Indiana were devastating Lessons from Indiana Slide 47 of 52 The U.S. is experiencing an expanding prescription drug and heroin epidemic that is driving increases in injection drug use A new and growing group of U.S. residents has become vulnerable to potentially explosive spread of HIV and HCV infection The events in Indiana were devastating but they were preventable Lessons from Indiana Slide 48 of 52 The U.S. is experiencing an expanding prescription drug and heroin epidemic that is driving increases in injection drug use A new and growing group of U.S. residents has become vulnerable to potentially explosive spread of HIV and HCV infection The events in Indiana were devastating but they were preventable Other communities are at risk 16
17 Lessons from Indiana Slide 49 of 52 The U.S. is experiencing an expanding prescription drug and heroin epidemic that is driving increases in injection drug use A new and growing group of U.S. residents has become vulnerable to potentially explosive spread of HIV and HCV infection The events in Indiana were devastating but they were preventable Other communities are at risk and the number could grow Lessons from Indiana Slide 50 of 52 The U.S. is experiencing an expanding prescription drug and heroin epidemic that is driving increases in injection drug use A new and growing group of U.S. residents has become vulnerable to potentially explosive spread of HIV and HCV infection The events in Indiana were devastating but they were preventable Other communities are at risk and the number could grow It could happen again Lessons from Indiana Slide 51 of 52 The U.S. is experiencing an expanding prescription drug and heroin epidemic that is driving increases in injection drug use A new and growing group of U.S. residents has become vulnerable to potentially explosive spread of HIV and HCV infection The events in Indiana were devastating but they were preventable Other communities are at risk and the number could grow It could happen again but it doesn t have to 17
18 Acknowledgments Scott and Clark County Health Departments Scott County Sheriff s Office Foundations Family Medicine Scott Memorial Hospital Indiana State Department of Health Indiana Family and Social Services Administration Indiana University School of Medicine School of Public Health Louisville 550 Clinic Centers for Disease Control and Prevention Division of HIV/AIDS Prevention Division of Viral Hepatitis Division of STD Prevention National Center for Injury Prevention and Control Office of Public Health Preparedness and Response Health Resources and Services Administration Substance Abuse and Mental Health Services Administration Slide 52 of 52 18
U.S. Counties Vulnerability to Rapid Dissemination of HIV/HCV Infections Among People Who Inject Drugs
U.S. Counties Vulnerability to Rapid Dissemination of HIV/HCV Infections Among People Who Inject Drugs Michelle Van Handel, MPH Health Scientist National Center for HIV/AIDS, Viral Hepatitis, STDs and
More informationHIV Transmission and Injection Drug Use: Lessons From the Indiana Outbreak. Diane M. Janowicz
HIV Transmission and Injection Drug Use: Lessons From the Indiana Outbreak 2016 Diane M. Janowicz ABSTRACT: A recent outbreak of HIV infection centered in the rural town of Austin in Scott County, Indiana,
More informationHepatitis A and B outbreaks in Massachusetts,
Hepatitis A and B outbreaks in Massachusetts, 2017-2018 Shauna Onofrey, MPH Viral Hepatitis Surveillance Coordinator Massachusetts Department of Public Health Massachusetts Background Population: 6.86
More informationPlacing the United States on the Path Toward the Elimination of Hepatitis C as a Public Health Threat
Placing the United States on the Path Toward the Elimination of Hepatitis C as a Public Health Threat John W. Ward, M.D Division of Viral Hepatitis National Center for HIV/AIDS, Viral Hepatitis, STD &
More informationThe National Infrastructure for Hepatitis C: Is There Anyone Home? December 21, 2015
The National Infrastructure for Hepatitis C: Is There Anyone Home? December 21, 2015 December 21, 2015 2 December 21, 2015 3 Can we eliminate hepatitis C? Treatments December 21, 2015 4 We Have the Roadmap
More informationHepatitis B Virus and the Opioid Crisis
Hepatitis B Virus and the Opioid Crisis Alice Asher, RN, Ph.D. Epidemiology and Surveillance Branch Division of Viral Hepatitis National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Centers
More informationHepatitis C in Massachusetts Epidemiology and Public Health Response
Massachusetts Department of Public Health Bureau of Infectious Disease and Laboratory Sciences Hepatitis C in Massachusetts Epidemiology and Public Health Response Shauna Onofrey, MPH, Viral Hepatitis
More informationObstacles and Opportunities on Our Path Toward Eliminating Viral Hepatitis
Obstacles and Opportunities on Our Path Toward Eliminating Viral Hepatitis Jonathan Mermin, MD, MPH National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention Centers for Disease Control and
More information1 HB By Representative Williams (JD) 4 RFD: Health. 5 First Read: 09-JAN-18 6 PFD: 11/28/2017. Page 0
1 HB37 2 188862-1 3 By Representative Williams (JD) 4 RFD: Health 5 First Read: 09-JAN-18 6 PFD: 11/28/2017 Page 0 1 188862-1:n:11/16/2017:PMG/tj LSA2017-3516 2 3 4 5 6 7 8 SYNOPSIS: This bill would establish
More informationO NEILL INSTITUTE PRESENTATION TITLE GOES HERE
O NEILL INSTITUTE PRESENTATION TITLE GOES HERE 1 Preventing Infectious Disease O NEILL INSTITUTE Transmission Among People who PRESENTATION TITLE GOES Inject Drugs: HERE Observations and Lessons from Scott
More informationHIV Surveillance in Urban and Nonurban Areas. National Center for HIV/AIDS, Viral Hepatitis, STD & TB Prevention Division of HIV/AIDS Prevention
HIV Surveillance in Urban and Nonurban Areas National Center for HIV/AIDS, Viral Hepatitis, STD & TB Prevention Division of HIV/AIDS Prevention HIV Infection in Urban and Nonurban Areas Many ways to characterize
More informationAlabama s Emerging Hepatitis C Epidemic and Vulnerability to an Outbreak of HIV Infection Among Persons Who Inject Drugs
Alabama s Emerging Hepatitis C Epidemic and Vulnerability to an Outbreak of HIV Infection Among Persons Who Inject Drugs James W. Galbraith MD Associate Professor Department of Emergency Medicine UAB Medicine
More informationSaskatchewan HIV Strategy: Social Network Approach
Saskatchewan HIV Strategy: Social Network Approach Dr. Johnmark Opondo MHO Provincial Leadership Team (PLT) CATIE Forum: New Science, New Directions in HIV and HCV September 18, 2013 Toronto, Canada A
More informationTargeted Outreach & Other Strategies for Increasing HCV Testing
Targeted Outreach & Other Strategies for Increasing HCV Testing Working in Settings that Serve High-Risk Populations Webcast 2.4 Presented By: Denise Stinson, MN, RN Tacoma-Pierce County Health Department
More informationHIV Testing. ECHO Hep C. Judith Feinberg, MD June 22, 2017
HIV Testing ECHO Hep C Judith Feinberg, MD June 22, 2017 Overview A few basics HIV epidemiology in the US HIV testing Time course of HIV-1 infection symptoms HIV proviral DNA symptoms window period HIV
More informationSeptember 1, The Honorable Tom Price, MD Secretary Department of Health and Human Services 200 Independence Avenue SW Washington, DC 20201
September 1, 2017 The Honorable Tom Price, MD Secretary Department of Health and Human Services 200 Independence Avenue SW Washington, DC 20201 Dear Secretary Price: The National Association of County
More informationSyringe Exchange Research Update Harm Reduction Coalition August 2008
Syringe Exchange Research Update August 2008 Introduction This overview and annotated bibliography summarizes key recent research on syringe exchange programs in the United States and related data on injection
More informationAge-Adjusted Rates of Death Related to POs and Heroin,
Learning Objectives Upon completion, participants should be able to: Incorporate available tools to screen patients for IDU into routine practice Develop processes to mitigate infectious diseases risks
More informationPresenters. Session Objectives. Session Overview. Cluster Investigations in Rural Wisconsin
Public Health Nurses, Hepatitis C, Injection Drug Use and Heroin Sheila Guilfoyle Viral Hepatitis Prevention Coordinator Division of Public Health Wisconsin Department of Health Services Wisconsin Public
More informationAdditional North Carolina Projects
Additional North Carolina Projects William Zule, Dr.P.H. www.rti.org RTI International is a trade name of Research Triangle Institute Risk Groups Injecting drug users (IDUs) Non-injecting drug users (non-idus)
More informationGetting to Zero in California: Integration of HIV Prevention and Surveillance
Getting to Zero in California: Integration of HIV Prevention and Surveillance Steve Gibson, MSW and Deanna Sykes, PhD CDPH, Office of AIDS November 27, 2017 Learning Objectives Understand reasons for integrated
More informationThe Geography of Infectious Diseases Related to the Opioid Epidemic. Patrick Sullivan, DVM, PhD Emory University March 12, 2018
The Geography of Infectious Diseases Related to the Opioid Epidemic Patrick Sullivan, DVM, PhD Emory University March 12, 2018 Presentation Outline The importance of infectious diseases in the opioid epidemic
More informationCherokee Nation HCV Program: From Evaluation to Cure to Elimination
Cherokee Nation HCV Program: From Evaluation to Cure to Elimination Jorge Mera, MD, FACP Whitney Essex, MSN, FNP BC Objectives Why is HCV a problem? Define elimination as it relates to infectious diseases
More informationTri-County Region Opioid Trends Clackamas, Multnomah, and Washington, Oregon. Executive Summary
Tri-County Region Opioid Trends Clackamas, Multnomah, and Washington, Oregon 2016 Executive Summary 20.8 million people in the United States have a substance use disorder (not limited to opioids), equivalent
More informationNumbers HCV and HIV Epidemiology in the US
By The Numbers HCV and HIV Epidemiology in the US Coinfection Fridays Session 1 18 January 2019 Christopher B. Hurt, MD Associate Professor of Medicine Co-Director, North Carolina AIDS Training & Education
More informationNIDA Responds to the Syndemic of Opioids, Viral Hepatitis and HIV. Wilson M. Compton, M.D., M.P.E. Deputy Director, National Institute on Drug Abuse
NIDA Responds to the Syndemic of Opioids, Viral Hepatitis and HIV Wilson M. Compton, M.D., M.P.E. Deputy Director, National Institute on Drug Abuse Virtually All of the U.S. Have Increased Drug Overdoses:
More informationThe Syndemics of HIV, Hepatitis, and Overdose
The Syndemics of HIV, Hepatitis, and Overdose Sara Zeigler Associate Director for Policy Office of Policy, Planning and Partnerships (proposed) Centers for Disease Control and Prevention National Center
More informationPublic Health Surveillance Yesterday, Today and Tomorrow Alfred DeMaria, Jr., M.D. Massachusetts Department of Public Health
Public Health Surveillance Yesterday, Today and Tomorrow Alfred DeMaria, Jr., M.D. Massachusetts Department of Public Health 1 History of Notifiable Diseases in Massachusetts 1842 Registration of births
More informationHigh Impact Prevention for People Who Inject Drugs. June 30, 2015
High Impact Prevention for People Who Inject Drugs June 30, 2015 Webinar Agenda Introduction & Background o NASTAD Drug User Health: Challenges and Opportunities for Health Departments o Alessandra Ross,
More informationThe Illicit Injection of Prescription Opioids in Scott County, Indiana: Risks and Rewards
The Illicit Injection of Prescription Opioids in Scott County, Indiana: Risks and Rewards Jon E. Zibbell, PhD Behavioral Health Program RTI International Atlanta, Georgia RTI International is a registered
More informationThe Opioid Addiction Emergency In Virginia June 8, 2017
The Opioid Addiction Emergency In Virginia June 8, 2017 Marissa J. Levine, MD MPH State Health Commissioner Virginia Department of Health Chronic Disease of Addiction Definition: A primary, chronic disease
More informationHigh Impact Prevention: Science, Practice, and the Future of HIV
High Impact Prevention: Science, Practice, and the Future of HIV Jonathan Mermin, MD, MPH National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Centers for Disease Control and Prevention
More informationHarm Reduction. West Virginia Rural Health Conference, October 17, 2018
Harm Reduction West Virginia Rural Health Conference, October 17, 2018 Michael E. Kilkenny, MD, MS! Physician Director! Cabell-Huntington Health Department! 703 7 th Avenue, Huntington, WV 25701! 304-523-6483!
More informationHIV/AIDS EPIDEMIOLOGY. Rachel Rivera, MD Assistant Professor Infectious Diseases UT Southwestern Medical Center November 14, 2014
HIV/AIDS EPIDEMIOLOGY Rachel Rivera, MD Assistant Professor Infectious Diseases UT Southwestern Medical Center November 14, 2014 HOUSEKEEPING ANNOUNCEMENTS AUDIO Can you hear us? You will be accessing
More informationMortality Slide Series. National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Division of HIV/AIDS Prevention
Mortality Slide Series National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Division of HIV/AIDS Prevention HIV Mortality Slides An analysis of trends in rates and distributions of deaths
More informationVIRGINIA S OPIOID & HEROIN OVERDOSE EPIDEMIC
1 VIRGINIA S OPIOID & HEROIN OVERDOSE EPIDEMIC Virginia Association of Counties November 14, 2016 The Honorable William A. Hazel, Jr., M.D. Secretary of Health and Human Resources 1999 - Estimated drug
More informationCDC s Response to the Viral Hepatitis/Opioid Syndemic
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Division of Viral Hepatitis CDC s Response to the Viral Hepatitis/Opioid Syndemic A Blythe Ryerson, PhD, MPH Associate Director for
More informationHIV and Hepatitis C Infection among Persons who Inject Drugs: Global Overview and Policy Implications
HIV and Hepatitis C Infection among Persons who Inject Drugs: Global Overview and Policy Implications Don Des Jarlais, Ph.D. Professor of Psychiatry, Icahn School of Medicine at Mount Sinai UNODC 2014
More informationPublic Health Approaches to Substance Misuse and Addictions
35 th Annual Alaska Health Summit Public Health Approaches to Substance Misuse and Addictions Jay C. Butler, MD, FAAP, MACP, FIDSA Chief Medical Officer, Alaska Dept of Heath & Social Services Director,
More informationMortality Slide Series. National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Division of HIV/AIDS Prevention
Mortality Slide Series National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Division of HIV/AIDS Prevention HIV Mortality Slides An analysis of trends in rates and distributions of deaths
More information2017 State Of The County Health Report Jones County, NC
217 State Of The County Health Report Jones County, NC Promoting sound health policies, preventing and controlling the spread of disease, and safeguarding the integrity of the environment for all citizens
More informationHEPATITIS C SURVEILLANCE IN NYC AN OVERVIEW OF PROJECTS
HEPATITIS C SURVEILLANCE IN NYC AN OVERVIEW OF PROJECTS P E R M I N D E R K H O S A, M P H S T A T E N I S L A N D H E P C T A S K F O R C E M E E T I N G, D A T E 0 3 / 2 6 / 2 0 1 5 HEPATITIS C SURVEILLANCE
More informationTB Outbreak in a Homeless Shelter
TB Outbreak in a Homeless Shelter Objectives Epidemiology of Outbreak Population Health Interventions Population Health Goals 2007 One active case identified Less than compliant Prolonged recovery Contact
More informationGreenbrier County. West Virginia Board of Pharmacy Prescription Opioid Problematic Prescribing Indicators County Report
West Virginia Board of Pharmacy Prescription Opioid Problematic Prescribing Indicators Report The West Virginia Violence and Injury Prevention Program ( VIPP), in collaboration with the West Virginia Board
More informationDISCLOSURES. This activity is jointly provided by Northwest Portland Area Indian Health Board and Cardea
DISCLOSURES This activity is jointly provided by Northwest Portland Area Indian Health Board and Cardea Cardea Services is approved as a provider of continuing nursing education by Montana Nurses Association,
More informationSUICIDE IN SAN DIEGO COUNTY:
SUICIDE IN SAN DIEGO COUNTY: 1998-2007 www.sdchip.org Contents www.sdchip.org SUICIDE IN SAN DIEGO COUNTY: 1998-2007 CHIP's Message Dear Reader, Community Health Improvement Partners (CHIP) is pleased
More informationIn accordance with 902 KAR 2:020, cases of acute hepatitis A should be reported within 24 hours.
Kentucky Department for Public Health KY7-89 - Acute Hepatitis A Outbreak Weekly Report Morbidity and Mortality Weekly Report (MMWR) Week May, 8 May, 8 Brief Description of Outbreak: In November 7, the
More informationOpioid Deaths in South Carolina. Daniela Nitcheva, PhD Division of Biostatistics Bureau of Public Health Statistics
Opioid Deaths in South Carolina Daniela Nitcheva, PhD Division of Biostatistics Bureau of Public Health Statistics Death Certificates ICD-10 Codes Literal text for cause of death is sent to the National
More informationHIV & HCV in TN: State of the State
HIV & HCV in TN: State of the State Vanderbilt CCC HIV Symposium Nashville, TN / November 2, 2018 Carolyn Wester, MD, MPH TDH HIV/STD/VH Program Outline HIV Epidemiology HIV Continuum of Care HIV Vulnerability
More informationHospitalizations for Infective Endocarditis Among Individuals Using Opioids in Philadelphia,
Hospitalizations for Infective Endocarditis Among Individuals Using Opioids in Philadelphia, 2008-2015 Lia N. Pizzicato, MPH CSTE Applied Epidemiology Fellow Philadelphia Department of Public Health Northeast
More informationThe Opioid Epidemic: HHS Response
The Opioid Epidemic: HHS Response Christopher M. Jones, PharmD, MPH Acting Associate Deputy Assistant Secretary (Science and Data Policy) Office of the Assistant Secretary for Planning and Evaluation U.S.
More informationPREVENTION OF HCV IN PEOPLE WHO INJECT DRUGS
PREVENTION OF HCV IN PEOPLE WHO INJECT DRUGS Holly Hagan, PhD Professor Co-Director, Center for Drug Use and HIV Research Principal Investigator, HCV Synthesis Project New York University HCV prevalence
More informationUtilizing CQI to Improve the Health of Supportive Housing Residents The North American Housing and HIV/AIDS Research Summit VII September 25-27, 2013
Utilizing CQI to Improve the Health of Supportive Housing Residents The North American Housing and HIV/AIDS Research Summit VII September 25-27, 2013 Montréal, Canada MISSION To provide 100% access to
More informationResponding to the Prescription Opioid and Heroin Crisis: An Epidemic of Addiction
Responding to the Prescription Opioid and Heroin Crisis: An Epidemic of Addiction Andrew Kolodny, MD Co-Director, Opioid Policy Research Collaborative Heller School for Social Policy and Management Brandeis
More informationAddressing the Opioid Epidemic in Tennessee
Addressing the Opioid Epidemic in Tennessee A Multidisciplinary Approach Melissa McPheeters, PhD, MPH Director, Informatics and Public Health Analytics 26 108 733 *Source: CDC References Centers for
More informationIllustrating HIV/AIDS in the United States Update
Illustrating HIV/AIDS in the United States 2016 Update About AIDSVu AIDSVu is a compilation of interactive, online maps that allows users to visually explore the HIV epidemic in the U.S. alongside critical
More informationEmergency Department Boarding of Psychiatric Patients in Oregon
College of Public Health and Human Sciences Emergency Department Boarding of Psychiatric Patients in Oregon Jangho Yoon, PhD, Jeff Luck, PhD April 25, 2017 Scope Quantify the extent of psychiatric emergency
More informationBarbour County. West Virginia Board of Pharmacy Prescription Opioid Problematic Prescribing Indicators County Report Barbour County
County West Virginia Board of Pharmacy Prescription Opioid Problematic Prescribing Indicators County Report County The West Virginia Violence and Injury Prevention Program ( VIPP), in collaboration with
More informationThe LENOWISCO Health District (LHD) is located in the heart of the beautiful Appalachian mountains of southwest Virginia, extending east from the
The LENOWISCO Health District (LHD) is located in the heart of the beautiful Appalachian mountains of southwest Virginia, extending east from the Cumberland Gap, and bordering Kentucky and Tennessee. Much
More informationBruce Kreter, PharmD Senior Director, Global HCV Medical Affairs Gilead Sciences, Inc.
CDC Foundation & Viral Hepatitis Action Coalition: Summit for the Elimination of Hepatitis B and Hepatitis C as Public Health Threats in the United States Bruce Kreter, PharmD Senior Director, Global HCV
More informationMarch XX, Washington, DC Washington, DC Washington, DC Washington, DC 20515
March XX, 2017 The Honorable Thad Cochran The Honorable Patrick Leahy Chairman Vice Chairman United States Senate United States Senate Washington, DC 20510 Washington, DC 20510 The Honorable Rodney Frelinghuysen
More informationReceptive Anal Intercourse and HIV Infection
World Journal of AIDS, 2017, 7, 269-278 http://www.scirp.org/journal/wja ISSN Online: 2160-8822 ISSN Print: 2160-8814 Receptive Anal Intercourse and HIV Infection Gilbert R. Lavoie 1, John F. Fisher 2
More information4/12/2018. Opioid Addiction and Prescribing. Disclosure Statement of Financial Interest
Opioid Addiction and Prescribing Mitchell Mutter, MD Director of Special Projects Nashville, TN April 12, 2018 Disclosure Statement of Financial Interest I, Mitchell Mutter, DO NOT have a financial interest/arrangement
More informationHepatitis C COLVILLE FOCUSED DIAGNOSIS, MANAGEMENT, TREATMENT
Hepatitis C COLVILLE FOCUSED DIAGNOSIS, MANAGEMENT, TREATMENT Background and affiliations BS (MIT); 3 years in international health (Mexico City and Honduras with Peace Corps); MS (Colorado State University);
More informationMingo County. West Virginia Board of Pharmacy Prescription Opioid Problematic Prescribing Indicators County Report
West Virginia Board of Pharmacy Prescription Opioid Problematic Prescribing Indicators Report The West Virginia Violence and Injury Prevention Program ( VIPP), in collaboration with the West Virginia Board
More informationPutnam County. West Virginia Board of Pharmacy Prescription Opioid Problematic Prescribing Indicators County Report
West Virginia Board of Pharmacy Prescription Opioid Problematic Prescribing Indicators Report The West Virginia Violence and Injury Prevention Program ( VIPP), in collaboration with the West Virginia Board
More informationHarm Reduction in Nigeria
Harm Reduction in Nigeria Needs, gaps, and responses to ensure access to effective HIV prevention, treatment and care for people who inject drugs February 2018 This document is made possible by the generous
More informationHIV Testing. Susan Tusher, LMSW Program Coordinator The Kansas AIDS Education and Training Center
HIV Testing Susan Tusher, LMSW Program Coordinator The Kansas AIDS Education and Training Center The Number of Persons in the US Living with HIV Continues to Increase Over 1 Million people are estimated
More informationSyringe Exchange An Intervention that Works to Control the Spread of Hepatitis C and HIV. Health Department
Syringe Exchange An Intervention that Works to Control the Spread of Hepatitis C and HIV Wayne Crabtree Administrator, Louisville Metro Department of Public Health and Wellness According to the CDC Kentucky
More informationOregon s PDMP: An epidemiological assist tool
Oregon s PDMP: An epidemiological assist tool Todd Beran Center for Prevention and Health Promotion Oregon Health Authority PDMP TTAC Webinar February 13, 2013 1 Acknowledgements Lisa Millet, MSH, Section
More informationPresentation to the ARCH Program of the New Jersey HIV Planning Group January 19, 2017 Alexis Roth, PhD, MPH
Expanding STI Control & Pre-Exposure Prophylaxis (PrEP) to Prevent HIV among Persons Who Inject Drugs Presentation to the ARCH Program of the New Jersey HIV Planning Group January 19, 2017 Alexis Roth,
More informationIs Elimination of Hepatitis C Possible?
Is Elimination of Hepatitis C Possible? JORGE MERA, MD CHEROKEE NATION DISCLOSURE INFORMATION The presenter has nothing to disclose. Outline Scope of the problem Definitions Is elimination of HCV needed?
More informationAdvocating for Syringe Exchange Programs
Advocating for Syringe Exchange Programs AMERICAN BAR ASSOCIATION AIDS COORDINATING COMMITTEE HIV Law & Practice Conference 2018 New Orleans, LA February 22, 2018 William McColl Vice President for Policy
More informationOpioid Use and Misuse: History, Trends, And The Oregon Opioid Initiative
Opioid Use and Misuse: History, Trends, And The Oregon Opioid Initiative John W. McIlveen, Ph.D., LMHC, State Opioid Treatment Authority, Oregon Health Authority, Addictions and Mental Health Division
More informationPocahontas County. West Virginia Board of Pharmacy Prescription Opioid Problematic Prescribing Indicators County Report
West Virginia Board of Pharmacy Prescription Opioid Problematic Prescribing Indicators Report The West Virginia Violence and Injury Prevention Program ( VIPP), in collaboration with the West Virginia Board
More informationKanawha County. West Virginia Board of Pharmacy Prescription Opioid Problematic Prescribing Indicators County Report
West Virginia Board of Pharmacy Prescription Opioid Problematic Prescribing Indicators Report The West Virginia Violence and Injury Prevention Program ( VIPP), in collaboration with the West Virginia Board
More informationSan Francisco Department of Public Health Program Collaboration and Service Integration Surveillance Baseline Assessment
Background and Purpose San Francisco Department of Public Health This syndemics assessment is the first step in developing a sustainable system of primary prevention and clinical care in San Francisco
More informationSYRINGE SERVICES PROGRAMS IN INDIANA
SYRINGE SERVICES PROGRAMS IN INDIANA Erika L. Chapman, MPH, CPH, CHES, RYT- 200 Harm Reduction Program Manager Division of HIV, STD, Viral Hepatitis Indiana State Department of Health What is Harm Reduction?
More informationPositive Living Conference
Positive Living Conference Ft. Walton Beach, Thomas Liberti Chief, Bureau of HIV/AIDS Department of Health March 11, 2011 Tallahassee, 1 The Epidemic in, 2010 60% White Population: 18.8 million (4 th 16%
More informationTrends in HIV Incidence and Prevalence in the United States
Trends in HIV Incidence and Prevalence in the United States Irene Hall, PhD, FACE 7th International Workshop on HIV Transmission Washington, DC, July 20, 2012 National Center for HIV/AIDS, Viral Hepatitis,
More informationState of Alabama HIV Surveillance 2013 Annual Report Finalized
State of Alabama HIV Surveillance 2013 Annual Report Finalized Prepared by: Division of STD Prevention and Control HIV Surveillance Branch Contact Person: Allison R. Smith, MPH Allison.Smith@adph.state.al.us
More informationCharacterising hepatitis C virus transmission dynamics in a highrisk incarcerated population
Characterising hepatitis C virus transmission dynamics in a highrisk incarcerated population Neil Bretaña, Lies Boelen, Rowena Bull, Suzy Teutsch, Peter White, Andrew Lloyd, Fabio Luciani on behalf of
More informationPrEP 201: Beyond the Basics
NORTHWEST AIDS EDUCATION AND TRAINING CENTER PrEP 201: Beyond the Basics Joanne Stekler, MD MPH Associate Professor of Medicine University of Washington February 19, 2015 Disclosures and Disclaimers I
More informationOpioid Data for Local Governments in North Carolina
Opioid Data for Local Governments in North Carolina Mary Beth Cox, Stacy Taylor, and Adam Lovelady October 10, 2018 Speakers Adam Lovelady Associate Professor UNC School of Government Mary Beth Cox Substance
More informationThe Opioid Epidemic in Alabama
The Opioid Epidemic in Alabama The Problem and Ways to Address It Mark E. Wilson, MD Health Officer Jefferson County Department of Health HEADLINE: Community action needed as heroin deaths rapidly climb
More informationUpdate on Community-based harm reduction services in Nelson Mandela Bay 25/10/2018
Update on Community-based harm reduction services in Nelson Mandela Bay 25/10/2018 Overview Background to injecting drug use Overview of harm reduction Data on Hepatitis Summary of services provided by
More informationSyringe Exchange Programs: Getting Started
Syringe Exchange Programs: Getting Started Matt La Rocco, BS, CADC Harm Reduction & Community Outreach Specialist Louisville Metro Syringe Exchange Program Workshop Overview LMSEP Year One Data, How To
More informationFlu Watch. MMWR Week 3: January 14 to January 20, and Deaths. Virologic Surveillance. Influenza-Like Illness Surveillance
Flu Watch MMWR Week 3: January 14 to January 2, 218 All data are provisional and subject to change as more reports are received. Geographic Spread South Carolina reported widespread activity this week.
More informationTHE OPIOID EPIDEMIC AND HIV THE INDIANA HIV/HCV OUTBREAK: IMPLICATIONS FOR PREVENTION
Clinical Education Initiative Support@ceitraining.org THE OPIOID EPIDEMIC AND HIV THE INDIANA HIV/HCV OUTBREAK: IMPLICATIONS FOR PREVENTION John T. Brooks, MD 3/13/2017 The Opioid Epidemic and HIV The
More informationExperience with Pyrazinamide and Rifampin Regimens for Latent TB Infection
Experience with Pyrazinamide and Rifampin Regimens for Latent TB Infection Krista Powell, MD, MPH Co-Project Officer, National Surveillance for Severe Adverse Events Associated with LTBI Treatment Lead,
More informationTri-County Opioid Safety Coalition Data Brief December 2017 Clackamas, Multnomah, and Washington Counties
Medicaid-Funded Alternative Treatment for Back Pain in the Tri-County Region Key Findings The percentage of members with a back pain diagnosis who received an alternative treatment increased from 29% in
More informationSeble G. Kassaye, M.D., M.S. Assistant Professor of Medicine Division of Infectious Diseases and Travel Medicine Georgetown University
Seble G. Kassaye, M.D., M.S. Assistant Professor of Medicine Division of Infectious Diseases and Travel Medicine Georgetown University November 5, 2016 None HIV epidemiology Global U.S. Washington, D.C.
More informationImplementation of testing (and other interventions along the Continuum of Care)
Implementation of testing (and other interventions along the Continuum of Care) Jonathan Mermin, MD, MPH National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention U.S. Centers for Disease Control
More informationWorking with People Who Use Drugs in HIV Care Settings. August 29, 2017 Workshop C 2:00 3:30 p.m.
Working with People Who Use Drugs in HIV Care Settings August 29, 2017 Workshop C 2:00 3:30 p.m. Working with People Who Use Drugs in HIV Care Settings Facilitator: Liz Hall, CDPH Office of AIDS Matt Curtis,
More informationNational Viral Hepatitis Action Plan Priority Populations Approach
National Viral Hepatitis Action Plan Priority Populations Approach November 29, 2017 Corinna Dan, RN, MPH Office of HIV/AIDS and Infectious Disease Policy Office of the Assistant Secretary for Health Department
More informationBassett Medical Center PPS Community Profile
Bassett Medical Center PPS Community Profile Counties served: Delaware, Herkimer, Madison, Otsego, and Schoharie DEMOGRAPHICS 1 The Bassett Medical Center PPS s total population is 278,214. Age: Residents
More informationPoisoning Data for HIV/HCV Prevention Injury and Violence Prevention Unit
Channeling John Snow: Poisoning Data for HIV/HCV Prevention Injury and Violence Prevention Unit HIV Outbreak in Southeastern Indiana Community Outbreak of HIV in Rural Indiana Early 2015, investigation
More informationFlu Watch. MMWR Week 4: January 21 to January 27, and Deaths. Virologic Surveillance. Influenza-Like Illness Surveillance
Flu Watch MMWR Week 4: January 21 to January 27, 218 All data are provisional and subject to change as more reports are received. Geographic Spread South Carolina reported widespread activity this week.
More informationINTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D
INTER-AMERICAN DRUG ABUSE CONTROL COMMISSION C I C A D Secretariat for Multidimensional Security FIFTY-FIFTH REGULAR SESSION April 29 - May 1, 2014 Washington, D.C. OEA/Ser.L/XIV.2.55 CICAD/doc.2089/14
More informationClick to edit Master title style
Public Health Click to edit Master title style Positively Hennepin: The County s Strategy to End HIV Positively Hennepin Strategy Coordinator Hennepin County Public Health Department Key Points HIV Strategy
More information